LIH383 is a peptide-based inhibitor scaffold characterized by aromatic and hydrophobic residues that target structured protein interfaces. Its backbone supports extended or helical conformations depending on solvent. Researchers assess its stability, binding kinetics, and interaction hotspots. Applications include PPI modulation, inhibitor design, and mechanistic structural biology.
CAT No: R2802
Synonyms/Alias:LIH383; CHEMBL5194677; BDBM50589879; HY-P10333; CS-1051166
LIH383 is a specialized carbohydrate compound recognized for its unique structural attributes and versatility in biochemical research. As a synthetic oligosaccharide, LIH383 is distinguished by its well-defined glycosidic linkages and stereochemistry, making it a valuable tool for probing glycan-related biological processes. Researchers often turn to LIH383 when seeking to elucidate the roles of specific carbohydrate motifs in cellular communication, recognition events, or enzymatic pathways. Its chemical stability and compatibility with various analytical techniques further enhance its utility across multiple scientific domains, allowing for precise experimental design and reliable data acquisition.
Glycobiology Research: In the field of glycobiology, LIH383 serves as a model substrate for investigating the interactions between carbohydrates and proteins such as lectins, glycosidases, and glycosyltransferases. By providing a defined glycan structure, it enables researchers to dissect the specificity and affinity of protein-carbohydrate binding, facilitating the mapping of glycan-binding sites and the elucidation of molecular recognition mechanisms. This application is critical for understanding how glycosylation patterns influence cell signaling, immune responses, and pathogen-host interactions.
Enzyme Characterization: LIH383 is widely applied in enzymology for the characterization and kinetic analysis of carbohydrate-active enzymes. Its precise structure allows for the assessment of enzyme substrate specificity, catalytic efficiency, and reaction mechanisms. By utilizing LIH383 in enzymatic assays, scientists can identify key residues involved in substrate recognition and catalysis, which is essential for the rational design of enzyme inhibitors or the engineering of enzymes with altered specificities for research and industrial applications.
Analytical Standards Development: As a reference standard, LIH383 plays a crucial role in the development and validation of analytical methods for carbohydrate analysis. Techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and capillary electrophoresis rely on well-characterized standards to ensure accurate quantification and structural elucidation of oligosaccharides in complex biological samples. The availability of LIH383 as a benchmark compound supports the establishment of robust analytical protocols and contributes to quality control in glycomics research.
Drug Discovery and Design: The unique properties of LIH383 make it an attractive scaffold in early-stage drug discovery efforts targeting glycan-mediated processes. By serving as a template for the synthesis of glycomimetic compounds, it enables the exploration of novel therapeutic candidates that can modulate carbohydrate-protein interactions implicated in disease. Its use in structure-activity relationship studies helps identify key structural features responsible for biological activity, guiding the optimization of lead compounds with enhanced efficacy and selectivity.
Biomaterials Engineering: In the realm of biomaterials science, LIH383 is incorporated into the design of functionalized surfaces, hydrogels, or nanoparticles to impart specific recognition capabilities. Its integration into biomaterial platforms enables the creation of bioactive interfaces that mimic natural glycan presentations, promoting selective cell adhesion, tissue engineering, or targeted delivery applications. By leveraging the molecular precision of LIH383, researchers can fine-tune the biointeractivity of materials for advanced biomedical research and development.
Structural Biology: Structural biology studies benefit from the use of LIH383 as a probe for elucidating the three-dimensional architecture of glycan-binding proteins and complexes. Its defined conformation facilitates co-crystallization or NMR-based investigations, allowing scientists to visualize carbohydrate recognition at atomic resolution. Insights gained from these studies inform the rational design of molecules that can modulate glycan-protein interactions, advancing our understanding of molecular recognition and informing the development of innovative research tools.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More